Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices 45781 

Springfield, Virginia 22152; and must be 

filed no later than September 5, 2008. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745), all applicants for 

registration to import a basic class of 

any controlled substance in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: July 30, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–18045 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations (CFR), 

1301.34(a), this is notice that on June 5, 

2008, Boehringer Ingelheim Chemicals, 

Inc., 2820 N. Normandy Drive, 

Petersburg, Virginia 23805, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Phenylacetone (8501), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance to bulk 

manufacture amphetamine. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, VA. 22152; and must be 

filed no later than September 5, 2008. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745), all applicants for 

registration to import a basic class of 

any controlled substance in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: July 30, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–18055 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated March 10, 2008 and 

published in the Federal Register on 

March 19, 2008, (73 FR 14839), Roche 

Diagnostics Operations, Inc., Attn: 

Regulatory Compliance, 9115 Hague 

Road, Indianapolis, Indiana 46250, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Lysergic acid diethylamide (7315) I 

Alphamethadol (9605) .................. I 

Tetrahydrocannabinols (7370) ..... I 

Cocaine (9041) ............................. II 

Ecgonine (9180) ........................... II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to import the 

listed controlled substances for the 

manufacture of diagnostic products for 

distribution to its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Roche Diagnostics Operations, Inc. to 

import the basic classes of controlled 

substances is consistent with the public 

interest, and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

May 1, 1971, at this time. DEA has 

investigated Roche Diagnostics 

Operations, Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and § 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: July 30, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–18064 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated February 12, 2008 

and published in the Federal Register 

on February 21, 2008, (73 FR 9591), 

United States Pharmacopeial 

Convention, 12601 Twinbrook Parkway, 

Rockville, Maryland 20852, made 

application to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Cathinone (1235) .......................... I 

Methaqualone (2565) .................... I 

Lysergic acid diethylamide (7315) I 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ...... I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

Codeine-n-oxide (9053) ................ I 

Heroin (9200) ................................ I 

Amphetamine (1100) .................... II 

mstockstill on PROD1PC66 with NOTICES

45782 Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices 

Drug Schedule 

Methamphetamine (1105) ............. II 

Phenmetrazine (1631) .................. II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 

Phencyclidine (7471) .................... II 

Alphaprodine (9010) ..................... II 

Anileridine (9020) .......................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................. II 

Diphenoxylate (9170) .................... II 

Hydrocodone (9193) ..................... II 

Levorphanol (9220) ....................... II 

Meperidine (9230) ......................... II 

Methadone (9250) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) .................... II 

Noroxymorphone (9668) ............... II 

Alfentanil (9737) ............................ II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................. II 

The company plans to import 

reference standards for sale to 

researchers and analytical labs. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

United States Pharmacopeial 

Convention to import the basic classes 

of controlled substances is consistent 

with the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971, at this time. DEA 

has investigated United States 

Pharmacopeial Convention to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: July 29, 2008. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E8–17965 Filed 8–5–08; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated April 9, 2008 and 

published in the Federal Register on 

April 16, 2008, (73 FR 20715), Research 

Triangle Institute, Kenneth H. Davis, Jr., 

Hermann Building, East Institute Drive, 

P.O. Box 12194, Research Triangle, 

North Carolina 27709, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

1-(1-Phenylcyclohexyl)pyrrolidine 

(7458).

I 

1-[1-(2- 

Thienyl)cyclohexy]piperidine 

(7470).

I 

1-[1-(2- 

Thienyl)cyclohexyl]pyrrolidine 

(7473).

I 

1-Methyl-4-phenyl-4- 

propionoxypiperidine (9661).

I 

1-(2-Phenylethyl)-4-phenyl-4- 

acetoxypiperidine (9663).

I 

2,5-Dimethoxy-4-(n)- 

propylthiophenethylamine 

(7348).

I 

2,5-Dimethoxy-4- 

ethylamphetamine (7399).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4,5-Trimethoxyamphetamine 

(7390).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

3,4-Methylenedioxy-methamphetamine (7405).I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3-Methylfentanyl (9813) ................ I 

3-Methylthiofentanyl (9833) .......... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

4-Methylaminorex (cis isomer) 

(1590).

I 

4-Methoxyamphetamine (7411) .... I 

5-Methoxy-3,4- 

methylenedioxyamphetamine 

(7401).

I 

5-Methoxy-N,Ndiisopropyltryptamine (7439).I 

Acetorphine (9319) ....................... I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Acetyldihydrocodeine (9051) ........ I 

Acetylmethadol (9601) .................. I 

Allylprodine (9602) ........................ I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alpha-ethyltryptamine (7249) ........ I 

Drug Schedule 

Alphameprodine (9604) ................ I 

Alphamethadol (9605) .................. I 

Alpha-methylfentanyl (9814) ......... I 

Alpha-methylthiofentanyl (9832) ... I 

Alpha-methyltryptamine (7432) ..... I 

Aminorex (1585) ........................... I 

Benzethidine (9606) ...................... I 

Benzylmorphine (9052) ................. I 

Betacetylmethadol (9607) ............. I 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Beta-hydroxyfentanyl (9830) ......... I 

Betameprodine (9608) .................. I 

Betamethadol (9609) .................... I 

Betaprodine (9611) ....................... I 

Bufotenine (7433) ......................... I 

Cathinone (1235) .......................... I 

Clonitazene (9612) ....................... I 

Codeine methylbromide (9070) .... I 

Codeine-N-Oxide (9053) ............... I 

Cyprenorphine (9054) ................... I 

Desomorphine (9055) ................... I 

Dextromoramide (9613) ................ I 

Diampromide (9615) ..................... I 

Diethylthiambutene (9616) ............ I 

Diethyltryptamine (7434) ............... I 

Difenoxin (9168) ........................... I 

Dihydromorphine (9145) ............... I 

Dimenoxadol (9617) ..................... I 

Dimepheptanol (9618) .................. I 

Dimethylthiambutene (9619) ......... I 

Dimethyltryptamine (7435) ............ I 

Dioxaphetyl butyrate (9621) ......... I 

Dipipanone (9622) ........................ I 

Drotebanol (9335) ......................... I 

Ethylmethylthiambutene (9623) .... I 

Etonitazene (9624) ....................... I 

Etorphine except HCl (9056) ........ I 

Etoxeridine (9625) ........................ I 

Fenethylline (1503) ....................... I 

Furethidine (9626) ........................ I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Heroin (9200) ................................ I 

Hydromorphinol (9301) ................. I 

Hydroxypethidine (9627) ............... I 

Ibogaine (7260) ............................. I 

Ketobemidone (9628) ................... I 

Levomoramide (9629) ................... I 

Levophenacylmorphan (9631) ...... I 

Lysergic acid diethylamide (7315) I 

Marihuana (7360) ......................... I 

Mecloqualone (2572) .................... I 

Mescaline (7381) .......................... I 

Methaqualone (2565) .................... I 

Methcathinone (1237) ................... I 

Methyldesorphine (9302) .............. I 

Methyldihydromorphine (9304) ..... I 

Morpheridine (9632) ..................... I 

Morphine methylbromide (9305) ... I 

Morphine methylsulfonate (9306) I 

Morphine-N-Oxide (9307) ............. I 

Myrophine (9308) .......................... I 

N,N-Dimethylamphetamine (1480) I 

N-[1-(2-thienyl)methyl-4-piperidyl]- 

N-phenylpropanamide (9834).

I 

N-[1-benzyl-4-piperidyl]-Nphenylpropanamide (9818).I 

N-Benzylpiperazine (7493) ........... I 

N-Ethyl-3-piperidyl benzilate 

(7482).

I 

N-Ethylamphetamine (1475) ......... I 

N-Ethyl-l-phenylcyclohexylamine 

(7455).

I 

mstockstill on PROD1PC66 with NOTICES